How Johnson & Johnson’s $6.475 Billion Talc Settlement Impacts Black Women
By: Kori Hale
Pharmaceutical giant Johnson & Johnson (JNJ -0.44%) is set to pay $6.475 billion to settle lawsuits alleging its talc-based products, often associated with health concerns, caused cancer. This unprecedented agreement covers around 60,000 cases, marking a significant moment in the intersections of public health and corporate accountability. For Black women, who were selected by J&J as “the right place” to sell more baby powder to, specifically targeting “under-developed geographical areas,” this is perhaps an opportunity for financial reciprocity.